Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria A Assimon

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Chemical Science|June 14, 2021
Tryptophan scanning mutagenesis as a way to mimic the compound-bound state and probe the selectivity of allosteric inhibitors in cellsIsabelle R Taylor, Victoria A Assimon, Szu Yu Kuo, et al.
Plos Computational Biology|December 12, 2018
Predicting protein targets for drug-like compounds using transcriptomicsNicolas A Pabon, Yan Xia, Samuel K Estabrooks, et al.
Nature Chemical Biology|July 20, 2019
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspasesMatthew Ravalin, Panagiotis Theofilas, Koli Basu, et al.
The Journal of Biological Chemistry|April 13, 2015
Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone ComplementSarah N Fontaine, Jennifer N Rauch, Bryce A Nordhues, et al.
Cell Chemical Biology|August 9, 2016
Stabilizing the Hsp70-Tau Complex Promotes Turnover in Models of TauopathyZapporah T Young, Jennifer N Rauch, Victoria A Assimon, et al.
Nature Structural & Molecular Biology|May 6, 2018
Mapping interactions with the chaperone network reveals factors that protect against tau aggregationSue-Ann Mok, Carlo Condello, Rebecca Freilich, et al.
ACS Chemical Biology|January 15, 2019
CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer ActivityVictoria A Assimon, Yangzhong Tang, Jesse D Vargas, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2023
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney DiseaseAdriana M Hung, Victoria A Assimon, Hua-Chang Chen, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Chemical Science|June 14, 2021
Tryptophan scanning mutagenesis as a way to mimic the compound-bound state and probe the selectivity of allosteric inhibitors in cellsIsabelle R Taylor, Victoria A Assimon, Szu Yu Kuo, et al.
Plos Computational Biology|December 12, 2018
Predicting protein targets for drug-like compounds using transcriptomicsNicolas A Pabon, Yan Xia, Samuel K Estabrooks, et al.
Nature Chemical Biology|July 20, 2019
Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspasesMatthew Ravalin, Panagiotis Theofilas, Koli Basu, et al.
The Journal of Biological Chemistry|April 13, 2015
Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone ComplementSarah N Fontaine, Jennifer N Rauch, Bryce A Nordhues, et al.
Cell Chemical Biology|August 9, 2016
Stabilizing the Hsp70-Tau Complex Promotes Turnover in Models of TauopathyZapporah T Young, Jennifer N Rauch, Victoria A Assimon, et al.
Nature Structural & Molecular Biology|May 6, 2018
Mapping interactions with the chaperone network reveals factors that protect against tau aggregationSue-Ann Mok, Carlo Condello, Rebecca Freilich, et al.
ACS Chemical Biology|January 15, 2019
CB-6644 Is a Selective Inhibitor of the RUVBL1/2 Complex with Anticancer ActivityVictoria A Assimon, Yangzhong Tang, Jesse D Vargas, et al.
Journal of the American Society of Nephrology : JASN|October 6, 2023
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney DiseaseAdriana M Hung, Victoria A Assimon, Hua-Chang Chen, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Pageof 2